CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 150 enrolled
Drug / intervention
GreenLight HPSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00465101
NCT00465101Phase 4Completed
CompareCT.gov

A Prospective Clinical Study for GreenLight HPS in the Treatment of Obstructive Benign Prostatic Hyperplasia (BPH)

American Medical Systems·interventional·Posted Apr 24, 2007·Updated Oct 28, 2015

In Brief

A Phase 4 clinical trial evaluating GreenLight HPS for Benign Prostatic Hyperplasia. Completed, enrolled 150 participants across 9 sites.

Detailed Summary

To gain clinical experience with the GreenLight HPS System, a system designed to vaporize and coagulate tissue in the treatment of benign prostatic hyperplasia to reduce lower urinary tract symptoms.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBenign Prostatic Hyperplasia
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 24, 2007
Enrollment StartMay 1, 2007
Primary CompletionAug 1, 2012
Study CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 19.2 years ago

Interventions

GreenLight HPSdevice

Greenlight HPS laser system for treatment of BPH